Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;30(3):462-472.
doi: 10.5603/CJ.a2022.0075. Epub 2022 Aug 17.

Catheter-directed therapy to treat intermediateand high-risk pulmonary embolism: Personal experience and review of the literature

Affiliations
Review

Catheter-directed therapy to treat intermediateand high-risk pulmonary embolism: Personal experience and review of the literature

Arkadiusz Pietrasik et al. Cardiol J. 2023.

Abstract

Pulmonary embolism (PE) is the third leading cause of cardiovascular death in the western world. Prompt recognition, risk stratification, and individualized treatment are crucial to improve outcomes in patients with PE. Anticoagulation alone is a sufficient therapeutic option in low-risk patients, whereas primary reperfusion with systemic thrombolysis (ST) is usually chosen in high-risk patients. The choice of treatment in intermediate-risk patients is complex and depends on the clinical presentation. Catheter-directed therapy (CDTh) includes all therapies delivered via a catheter placed in the branches of the pulmonary arteries directly into the thrombus. Because ST bears a high risk of major bleeding and numerous patients have contraindications to ST, CDTh is an alternative to ST in intermediate- and high-risk PE patients. CDTh includes local thrombolysis using low-dose alteplase, ultrasound-assisted thrombolysis, and mechanical fragmentation and aspiration of the thrombi, as well as their combinations. In this review article, we have summarized devices and technical details for CDTh, discussed the efficacy and safety of CDTh in comparison to ST in previous clinical trials, and outlined future research directions regarding CDTh, both based on the literature and our personal experience from the local PE Response Team of the Center for the Management of Pulmonary Embolism (CELZAT) in Warsaw.

Keywords: catheter-based therapy; interventional cardiology; pulmonary embolism; review.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared

Figures

Figure 1
Figure 1
Common steps of catheter-directed therapy (CDTh) in pulmonary embolism; A. Access routes; B. Vascular access technique; C. CDTh delivery.
Central illustration
Central illustration
Devices approved for catheter-directed therapy (CDTh) in pulmonary embolism; A. Standard catheter-directed thrombolysis (CDL); B. Ultrasound-assisted CDL (EKOS™ Endovascular System); C. Aspiration-based catheter directed thrombectomy (CDT) (AngioJet™, Penumbra Indigo® System, AngioVac System); D. Thrombus entrapping using mesh discs (FlowTriever Infusion Aspiration System).

Similar articles

Cited by

References

    1. Baram M, Awsare B, Merli G. Pulmonary embolism in intensive care unit. Crit Care Clin. 2020;36(3):427–435. doi: 10.1016/j.ccc.2020.02.001. - DOI - PubMed
    1. Duffett L, Castellucci LA, Forgie MA. Pulmonary embolism: update on management and controversies. BMJ. 2020;370:m2177. doi: 10.1136/bmj.m2177. - DOI - PubMed
    1. Stone J, Hangge P, Albadawi H, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S276–S284. doi: 10.21037/cdt.2017.09.01. - DOI - PMC - PubMed
    1. Vyas V, Goyal A. Acute pulmonary embolism. Stat Pearls Publishing; 2022. - PubMed
    1. Waheed SM, Kudaravalli P, Hotwagner DT. Deep vein thrombosis. StatPearls [Internet] StatPearls Publishing; 2021. - PubMed

MeSH terms

Substances